The “COVID-killing” nanomaterial requires a continuous light source to produce antiviral properties, which creates “a self-cleaning effect,” according to a news release from the university.
In a study published in 2022, the now-patented coating was found to kill SARS-CoV-2 and fight the Zika virus, SARS, parainfluenza, rhinovirus and vesicular stomatitis.
Sudipta Seal, PhD, department chair of materials science and engineering at UCF, said the defectant’s patent was approved faster than usual, proving its “great value for combating viruses and pathogen-born infections.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.